Switzerland’s ender to provide rapid COVID-19 diagnostics tests for cabin crewender diagnostics, a Swiss firm specialising in rapid molecular biological tests, has announced a collaboration with a national Share XSwitzerland’s ender to provide rapid COVID-19 diagnostics tests for cabin crewhttps://pharmaphorum.com/news/switzerlands-ender-to-provide-rapid-covid-19-diagnostics-tests-for-cabin-crew/
UK cancer mutation testing firm Biofidelity raises $12mCambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect Share XUK cancer mutation testing firm Biofidelity raises $12mhttps://pharmaphorum.com/news/uk-cancer-mutation-testing-firm-biofidelity-raises-12m/
Coronavirus news roundup 09/04/2020As the number of coronavirus cases in the world exceeds 1.4 million, the pharma industry is pushing to Share XCoronavirus news roundup 09/04/2020https://pharmaphorum.com/views-and-analysis/coronavirus-news-roundup-09-04-2020/
Pharma given COVID-19 test ‘call to arms’ by health secretaryUK health secretary Matt Hancock has asked pharma and biotech firms to help the country find antibody tests Share XPharma given COVID-19 test ‘call to arms’ by health secretaryhttps://pharmaphorum.com/news/pharma-given-covid-19-test-call-to-arms-by-health-secretary/
Celltrion to develop coronavirus antibody and fast testSouth Korea’s Celltrion has joined the many pharma companies fighting the COVID-19 coronavirus outbreak, saying it is working Share XCelltrion to develop coronavirus antibody and fast testhttps://pharmaphorum.com/news/celltrion-antibody-and-fast-test/
FDA approves fast tests for coronavirus as US faces shortagesThe FDA has approved two fast tests for the coronavirus that is causing the COVID-19 epidemic, which are Share XFDA approves fast tests for coronavirus as US faces shortageshttps://pharmaphorum.com/news/fda-approves-fast-tests-for-coronavirus-as-us-faces-shortages/
Large scale tests for coronavirus ‘unfeasible’, says Roche CEOWidespread testing for the coronavirus is still unfeasible, Roche’s CEO Severin Schwan said in a press briefing on Share XLarge scale tests for coronavirus ‘unfeasible’, says Roche CEOhttps://pharmaphorum.com/news/large-scale-tests-for-coronavirus-unfeasible-says-roche-ceo/
FDA approves Roche’s MRSA test, allowing for faster screeningThe FDA has approved Roche’s MRSA test, a technology that could give healthcare providers the ability to detect Share XFDA approves Roche’s MRSA test, allowing for faster screeninghttps://pharmaphorum.com/news/fda-approves-roches-mrsa-test/
Genfit announces data from algorithm-based NASH testThe pharma company Genfit has announced supportive data from a study involving a non-invasive algorithm driven blood test Share XGenfit announces data from algorithm-based NASH testhttps://pharmaphorum.com/news/genfit-announces-data-from-potential-nash-blood-test/
